"One CBT explanation for the maintenance of OCD symptoms is that the person tends to have difficulties interpreting his or her feelings (Salkovskis, Shafran, Ranchman, & Freeston, 1999; Wahl, Salkovskis, & Cotter, 2008). Storch and Merlo (2006) suggested that OCD can be understood as thought–action fusion, implying that negative thoughts and negative actions are seen as synonymous. In thought–action fusion, individuals may mix up thoughts and reality, such as fearing that dangerous thoughts automatically lead to actions or that forbidden thoughts are as reprehensible as forbidden behavior (Shafran, Thordarson, & Rachman, 1996). "
[Show abstract][Hide abstract] ABSTRACT: Obsessive Compulsive Disorder (OCD) involves exaggerated or excessive worry about threatening and non-threatening stimuli coupled with impairing rituals believed to reduce anxiety. Autism Spectrum Disorders (ASD) are characterized by impairment in social and communicative activities as well as restricted and repetitive behaviors. Approximately 2% of children with ASD are also diagnosed with OCD. Although there is extensive research demonstrating the effectiveness of behavioral interventions for pediatric OCD, little is known about how effective these treatments are for children who have a dual diagnosis of OCD and ASD. This report describes a 12-year-old male with Autism who was treated successfully with cognitive behavioral therapy with exposure and response prevention. This case study provides initial support that cognitive-behavioral therapy is effective in symptom reduction for children with comorbid autism and OCD.
Journal of Autism and Developmental Disorders 10/2007; 38(5):977-81. DOI:10.1007/s10803-007-0457-2 · 3.34 Impact Factor
[Show abstract][Hide abstract] ABSTRACT: We report the case of adolescent male with obsessive-compulsive disorder (OCD) who had an incomplete response to combined cognitive-behavioral therapy (CBT) and sertraline before successful augmentation of CBT with aripiprazole. Standardized assessments indicated significant reductions in OCD symptomatology associated with both initial treatment and aripiprazole augmentation. This case suggests that aripiprazole may have utility as an augmenting agent of CBT in adolescents with OCD and underscores the need for conducting controlled studies to test this hypothesis.
Depression and Anxiety 02/2008; 25(2):172-4. DOI:10.1002/da.20303 · 4.41 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.